• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Mobilization of blood-derived stem and progenitor cells in normal subjects by granulocyte-macrophage- and granulocyte-colony-stimulating factors.

作者信息

Lane T A, Ho A D, Bashey A, Peterson S, Young D, Law P

机构信息

Blood and Marrow Transplant Program, Department of Medicine, University of California, San Diego, School of Medicine, USA.

出版信息

Transfusion. 1999 Jan;39(1):39-47. doi: 10.1046/j.1537-2995.1999.39199116893.x.

DOI:10.1046/j.1537-2995.1999.39199116893.x
PMID:9920165
Abstract

BACKGROUND

It was previously reported that the combination of granulocyte-macrophage-colony-stimulating factor (GM-CSF) and granulocyte-CSF (G-CSF) for 4 days mobilized more primitive CD34+ subsets than did either G-CSF or GM-CSF alone.

STUDY DESIGN AND METHODS

The studies determine the optimal number of days of growth factor dosing for mobilization and collection of peripheral blood progenitor cells, by increasing the days of administration of GM-CSF and/or G-CSF or employing the sequential administration of GM-CSF followed by G-CSF. Sixty normal subjects were given injections of G-CSF or GM-CSF alone; GM-CSF and G-CSF concurrently for 4, 5, or 6 days; or a sequential regimen of GM-CSF for 3 or 4 days followed by G-CSF for 2 or 3 days. A 10-L apheresis was performed 24 hours after the last dose.

RESULTS

The three most efficacious mobilization regimens consisted of sequential GM-CSF for 3 days followed by G-CSF for either 2 or 3 days and G-CSF alone for 5 days. Each of these regimens resulted in the collection of significantly greater numbers of CD34+ cells by apheresis than any of the 4-day dosing regimens with G-CSF and/or GM-CSF (sequential GM-CSF/G-CSF: 3 days/2 days = 3.58 +/- 0.53 x 106 CD34+ cells/kg; GM-CSF/G-CSF: 3 days/3 days = 4.45 +/- 1.08 x 10(6) CD34+ cells/kg; G-CSF: 5 days = 3.58 +/- 0.97 x 10(6) CD34+ cells/kg; all p<0.05 vs. G-CSF and/or GM-CSF for 4 days). Clonogenic assays generally paralleled the level of CD34+ cells. Regimens containing GM-CSF resulted in a higher percentage of the cells from primitive CD34+/CD38-/HLA-DR+ subset than G-CSF alone.

CONCLUSION

Compared with 4-day dosing regimens with G-CSF and/or GM-CSF, mobilization of CD34+ cells in normal subjects using sequential GM-CSF for 3 days followed by G-CSF for 2 or 3 days or using G-CSF alone for 5 days increased the number CD34+ cells that can be collected by a single 10-L apheresis 24 hours after the last dose of cytokine.

摘要

相似文献

1
Mobilization of blood-derived stem and progenitor cells in normal subjects by granulocyte-macrophage- and granulocyte-colony-stimulating factors.
Transfusion. 1999 Jan;39(1):39-47. doi: 10.1046/j.1537-2995.1999.39199116893.x.
2
Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation.通过粒细胞巨噬细胞集落刺激因子(GM-CSF)或粒细胞集落刺激因子(G-CSF)动员到正常供体外周血中的造血祖细胞的采集与富集:在异基因骨髓移植中的潜在作用
Blood. 1995 Jan 1;85(1):275-82.
3
Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.祖细胞动员的随机交叉试验:大剂量环磷酰胺加粒细胞集落刺激因子(G-CSF)与粒细胞巨噬细胞集落刺激因子加G-CSF的比较
J Clin Oncol. 2000 May;18(9):1824-30. doi: 10.1200/JCO.2000.18.9.1824.
4
Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both.由粒细胞集落刺激因子(G-CSF)、粒细胞-巨噬细胞集落刺激因子(GM-CSF)或两者联合动员的白细胞分离产物中的多能和定向分化CD34+亚群。
Exp Hematol. 1996 Nov;24(13):1460-8.
5
Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.粒细胞集落刺激因子与粒细胞巨噬细胞集落刺激因子联合强化化疗用于多发性骨髓瘤外周血干细胞动员和自体移植的随机对照研究
Biol Blood Marrow Transplant. 2004 Jun;10(6):395-404. doi: 10.1016/j.bbmt.2004.02.001.
6
Myelopoietin, a chimeric agonist of human interleukin 3 and granulocyte colony-stimulating factor receptors, mobilizes CD34+ cells that rapidly engraft lethally x-irradiated nonhuman primates.髓系生成素,一种人白细胞介素3和粒细胞集落刺激因子受体的嵌合激动剂,可动员CD34+细胞,这些细胞能迅速植入经致死剂量X射线照射的非人灵长类动物体内。
Exp Hematol. 1999 Oct;27(10):1557-68. doi: 10.1016/s0301-472x(99)00092-2.
7
Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.超越 CD34+ 细胞剂量:外周血造血干细胞动员方法(粒细胞集落刺激因子[G-CSF]、G-CSF 加plerixafor 或环磷酰胺 G-CSF/粒细胞-巨噬细胞[GM]-CSF)对集落形成单位-GM 数量、植入和第 100 天造血移植物功能的影响。
Transfusion. 2011 Sep;51(9):1995-2000. doi: 10.1111/j.1537-2995.2011.03085.x. Epub 2011 Mar 10.
8
GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.基于粒细胞巨噬细胞集落刺激因子的动员效应在正常健康供者用于异基因外周血干细胞移植中的作用
Bone Marrow Transplant. 2002 Jul;30(2):81-6. doi: 10.1038/sj.bmt.1703598.
9
A combination of low-dose cyclophosphamide and colony-stimulating factors is more cost-effective than granulocyte-colony-stimulating factors alone in mobilizing peripheral blood stem and progenitor cells.在动员外周血干细胞和祖细胞方面,低剂量环磷酰胺与集落刺激因子联合使用比单独使用粒细胞集落刺激因子更具成本效益。
Transfusion. 1998 Feb;38(2):209-15. doi: 10.1046/j.1537-2995.1998.38298193107.x.
10
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF.大剂量环磷酰胺后三种细胞因子方案的比较效果:粒细胞集落刺激因子、粒细胞-巨噬细胞集落刺激因子(GM-CSF)以及白细胞介素-3与GM-CSF序贯治疗。
J Clin Oncol. 1999 Apr;17(4):1296. doi: 10.1200/JCO.1999.17.4.1296.

引用本文的文献

1
Role of myeloid-derived suppressor cells in tumor recurrence.髓源性抑制细胞在肿瘤复发中的作用。
Cancer Metastasis Rev. 2023 Mar;42(1):113-142. doi: 10.1007/s10555-023-10079-1. Epub 2023 Jan 14.
2
Myeloid derived suppressor cells and the release of micro-metastases from dormancy.髓源性抑制细胞与休眠中小转移灶的释放。
Clin Exp Metastasis. 2021 Jun;38(3):279-293. doi: 10.1007/s10585-021-10098-8. Epub 2021 May 20.
3
Role of myeloid-derived suppressor cells in metastasis.髓系来源的抑制细胞在转移中的作用。
Cancer Metastasis Rev. 2021 Jun;40(2):391-411. doi: 10.1007/s10555-020-09947-x. Epub 2021 Jan 7.
4
Stable colony-stimulating factor 1 fusion protein treatment increases hematopoietic stem cell pool and enhances their mobilisation in mice.稳定的集落刺激因子 1 融合蛋白治疗可增加造血干细胞池,并增强其在小鼠中的动员。
J Hematol Oncol. 2021 Jan 6;14(1):3. doi: 10.1186/s13045-020-00997-w.
5
Filgrastim induced thrombocytopenia.粒细胞集落刺激因子诱导的血小板减少症。
BMJ Case Rep. 2020 Jun 30;13(6):e234584. doi: 10.1136/bcr-2020-234584.
6
Rationale and design of the granulocyte-macrophage colony stimulating factor in peripheral arterial disease (GPAD-3) study.粒细胞-巨噬细胞集落刺激因子在周围动脉疾病(GPAD-3)研究中的原理和设计。
Contemp Clin Trials. 2020 Apr;91:105975. doi: 10.1016/j.cct.2020.105975. Epub 2020 Mar 4.
7
Effect of progenitor cell mobilization with granulocyte-macrophage colony-stimulating factor in patients with peripheral artery disease: a randomized clinical trial.粒细胞-巨噬细胞集落刺激因子动员祖细胞对周围动脉疾病患者的影响:一项随机临床试验。
JAMA. 2013 Dec 25;310(24):2631-9. doi: 10.1001/jama.2013.282540.
8
Cell-based therapy for urinary incontinence.基于细胞的尿失禁治疗方法。
Korean J Urol. 2010 Jan;51(1):1-7. doi: 10.4111/kju.2010.51.1.1. Epub 2010 Jan 21.
9
Isolation and therapeutic potential of human haemopoietic stem cells.人造血干细胞的分离与治疗潜力。
Cytotechnology. 2003 Mar;41(2-3):111-31. doi: 10.1023/A:1024822722285.
10
Allogeneic peripheral blood stem cell collection as of 2008.截至2008年的异基因外周血干细胞采集。
Transfus Apher Sci. 2008 Jun;38(3):219-27. doi: 10.1016/j.transci.2008.04.011. Epub 2008 May 22.